• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼古丁成瘾的神经网络。

Neuronal networks of nicotine addiction.

机构信息

Facultad de Medicina, Universidad de Morón - Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina.

出版信息

Int J Biochem Cell Biol. 2010 Dec;42(12):1931-5. doi: 10.1016/j.biocel.2010.08.019. Epub 2010 Sep 15.

DOI:10.1016/j.biocel.2010.08.019
PMID:20833261
Abstract

Nicotine is the main psychoactive substance present in tobacco, targeting neuronal nicotinic acetylcholine receptors. The main effects of nicotine associated with smoking are nicotinic receptor activation, desensitization, and upregulation, with the subsequent modulation of the mesocorticolimbic dopaminergic system. However, there is a lack of a comprehensive explanation of their roles that effectively makes clear how nicotine dependence might be established on those grounds. Receptor upregulation is an unusual effect for a drug of abuse, because theoretically this implies less need for drug consumption. Receptor upregulation and receptor desensitization are commonly viewed as opposite, homeostatic mechanisms. We here review the available information on smoking addiction, especially under a recently presented model of nicotine dependence. In this model both receptor upregulation and receptor desensitization are responsible for establishing a biochemical mechanism of nicotine dependence, which have an important role in starting and maintaining tobacco addiction.

摘要

尼古丁是烟草中存在的主要精神活性物质,作用于神经元烟碱型乙酰胆碱受体。与吸烟相关的尼古丁的主要作用是烟碱型受体激活、脱敏和上调,随后调节中脑边缘多巴胺能系统。然而,目前还缺乏对其作用的全面解释,无法有效地阐明尼古丁依赖可能基于哪些机制。受体上调是一种滥用药物的异常效应,因为从理论上讲,这意味着对药物消费的需求减少。受体上调和受体脱敏通常被视为相反的、自身平衡的机制。我们在此综述了有关吸烟成瘾的现有信息,特别是在最近提出的尼古丁依赖模型下。在该模型中,受体上调和受体脱敏都负责建立尼古丁依赖的生化机制,该机制在启动和维持烟草成瘾方面起着重要作用。

相似文献

1
Neuronal networks of nicotine addiction.尼古丁成瘾的神经网络。
Int J Biochem Cell Biol. 2010 Dec;42(12):1931-5. doi: 10.1016/j.biocel.2010.08.019. Epub 2010 Sep 15.
2
Tobacco addiction: a biochemical model of nicotine dependence.烟草成瘾:尼古丁依赖的生化模型。
Med Hypotheses. 2010 May;74(5):884-94. doi: 10.1016/j.mehy.2009.11.004. Epub 2009 Dec 3.
3
Nicotinic receptors and stages of nicotine dependence.烟碱型乙酰胆碱受体与尼古丁依赖的阶段。
J Psychopharmacol. 2010 Jun;24(6):793-808. doi: 10.1177/0269881108100256. Epub 2009 Feb 27.
4
Nicotine addiction: the possible role of functional upregulation.尼古丁成瘾:功能上调的潜在作用。
Trends Pharmacol Sci. 2002 Mar;23(3):130-6. doi: 10.1016/S0165-6147(00)01979-9.
5
The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery.尼古丁和去甲烟碱对烟碱型乙酰胆碱受体亚型的药理活性:与尼古丁依赖及药物研发的相关性
J Neurochem. 2007 Apr;101(1):160-7. doi: 10.1111/j.1471-4159.2006.04355.x. Epub 2007 Jan 4.
6
Neurobiology of nicotine addiction: implications for smoking cessation treatment.尼古丁成瘾的神经生物学:对戒烟治疗的启示。
Am J Med. 2008 Apr;121(4 Suppl 1):S3-10. doi: 10.1016/j.amjmed.2008.01.015.
7
Nicotine addiction causes unique detrimental effects on women's brains.尼古丁成瘾对女性大脑造成独特的有害影响。
J Addict Dis. 2011 Apr;30(2):149-58. doi: 10.1080/10550887.2011.554782.
8
CB1 receptor antagonists for the treatment of nicotine addiction.用于治疗尼古丁成瘾的CB1受体拮抗剂。
Pharmacol Biochem Behav. 2005 Jun;81(2):387-95. doi: 10.1016/j.pbb.2005.01.024.
9
[Nicotine dependence].[尼古丁依赖]
Rev Pneumol Clin. 2000 Jun;56(3):177-83.
10
Cellular and synaptic mechanisms of nicotine addiction.尼古丁成瘾的细胞和突触机制。
J Neurobiol. 2002 Dec;53(4):606-17. doi: 10.1002/neu.10148.

引用本文的文献

1
Transcriptomic Dysregulation in Animal Models of Attention-Deficit Hyperactivity Disorder and Nicotine Dependence Suggests Shared Neural Mechanisms.注意力缺陷多动障碍和尼古丁依赖动物模型中的转录组失调提示存在共同的神经机制。
Brain Behav. 2025 Mar;15(3):e70444. doi: 10.1002/brb3.70444.
2
Exploring Neurobehaviour in Zebrafish Embryos as a Screening Model for Addictiveness of Substances.探索斑马鱼胚胎中的神经行为作为物质成瘾性的筛选模型。
Toxics. 2021 Oct 7;9(10):250. doi: 10.3390/toxics9100250.
3
Mutual assistance of nucleus accumbens cannabinoid receptor-1 and orexin receptor-2 in response to nicotine: a single-unit study.
伏隔核大麻素受体-1与食欲素受体-2在对尼古丁反应中的相互作用:一项单细胞研究
Res Pharm Sci. 2021 Mar 5;16(2):173-181. doi: 10.4103/1735-5362.310524. eCollection 2021 Apr.
4
Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula.冠狗牙花定类似物对烟碱型乙酰胆碱受体的选择性及其对小鼠内侧缰核的抑制活性
Int J Biochem Cell Biol. 2017 Nov;92:202-209. doi: 10.1016/j.biocel.2017.10.006. Epub 2017 Oct 16.
5
Evaluation of Individuals at Risk for COPD: Beyond the Scope of the Global Initiative for Chronic Obstructive Lung Disease.慢性阻塞性肺疾病(COPD)高危个体的评估:超越慢性阻塞性肺疾病全球倡议的范畴
Chronic Obstr Pulm Dis. 2016 Jun 28;3(3):653-667. doi: 10.15326/jcopdf.3.3.2016.0129.
6
Gestational exposure to perfluorooctanoic acid (PFOA): Alterations in motor related behaviors.孕期暴露于全氟辛酸(PFOA):运动相关行为的改变。
Neurotoxicology. 2017 Jan;58:110-119. doi: 10.1016/j.neuro.2016.11.008. Epub 2016 Nov 22.
7
Nicotine regulates activity of lateral habenula neurons via presynaptic and postsynaptic mechanisms.尼古丁通过突触前和突触后机制调节外侧缰核神经元的活动。
Sci Rep. 2016 Sep 6;6:32937. doi: 10.1038/srep32937.
8
Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake.神经元烟碱型乙酰胆碱受体调节剂可减少糖分摄入。
PLoS One. 2016 Mar 30;11(3):e0150270. doi: 10.1371/journal.pone.0150270. eCollection 2016.
9
Determination of Nicotine in Tobacco by Chemometric Optimization and Cation-Selective Exhaustive Injection in Combination with Sweeping-Micellar Electrokinetic Chromatography.化学计量学优化结合阳离子选择性完全进样与扫集-胶束电动色谱法测定烟草中的尼古丁
J Anal Methods Chem. 2015;2015:869719. doi: 10.1155/2015/869719. Epub 2015 May 26.
10
Intra-subunit flexibility underlies activation and allosteric modulation of neuronal nicotinic acetylcholine receptors.亚基内的灵活性是神经元烟碱型乙酰胆碱受体激活和变构调节的基础。
Neuropharmacology. 2014 Apr;79:420-31. doi: 10.1016/j.neuropharm.2013.12.017. Epub 2013 Dec 25.